Thursday, April 23, 2026
35 C
Bengaluru

Digital Noise to Digital Voice – A 4-Module Workshop for Pharma People

When Covid19 struck for the first time in March 2020, the pharma industry was not ready for the sudden and dramatic changes, that disrupted the healthcare industry completely.

And to deal with the sudden and dramatic changes, professionals in the pharma industry needed awareness, education, and knowledge sharing.

MedicinMan took up this responsibility in partnership with CredoWeb to create “Digital Excellence Pharma Academy” –DEPA and conducted 50+ online sessions with renowned Indian and International healthcare industry influencers as faculty members, from May 2020 to April 2021.

And DEPA1.0 was a great success!

Now is time to learn how to perform marketing and sales activities using the new technology in the New Normal on practice! 

We go into the why, how, and what of doing digital. If you were a Listener till now, you’ll be a Player now!

MedicinMan in partnership with CredoWeb is again coming up with the 2.0 version of our DEPA with international and Indian faculty – Dr. Peter Velev, a medical doctor and pharma industry veteran, Praful Akali, founder and CEO of Medulla Communications and Salil Kallianpur, pharma marketing veteran and digital brand coach.

The workshop sessions will be moderated by Anup Soans, Editor @ MedicinMan to discuss: International and Indian case studies Interactive Q & A sessions

We are launching DEPA 2.0 Workshop with four Modules beginning Saturday, October 30, 2021.

For registration and program details – https://medicinman.net/register-for-depa-2-0/

For any questions and how to join DEPA 2.0 please write to: anupsoans@medicinman.net

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img